Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

282 trials

NCT06209619
Recruiting
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
Phase 1 · United States · 1 site
Registry update: 27 Feb 2026
NCT06244368
Recruiting
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Phase 2 · China · 1 site
Registry update: 14 May 2025
NCT06045247
Recruiting
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Phase 2 · United States · 1 site
Registry update: 25 Sept 2026
NCT05672251
Recruiting
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · United States · 1 site
Registry update: 8 Oct 2026
NCT06439173
Recruiting
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Not applicable · Spain · 1 site
Registry update: 3 Jun 2024
NCT06481826
Recruiting
Glofitamab in Chinese Patients With R/R DLBCL
Not applicable · China · 1 site
Registry update: 27 Mar 2026
NCT06091865
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Phase 3 · Austria, Australia, Belgium, Brazil, Chile, Czechia, Germany, Spain, France, United Kingdom, Ireland, Israel, Italy, South Korea, Malaysia, Poland, Singapore, Thailand, Taiwan, United States · 195 sites
Registry update: 4 Nov 2026
NCT06287398
Recruiting
Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Phase 2 · Australia · 1 site
Registry update: 22 Jul 2024
NCT06299553
Recruiting
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Not applicable · Italy · 1 site
Registry update: 22 May 2024
NCT05541341
Recruiting
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Not applicable · Brazil · 4 sites
Registry update: 10 Nov 2026
NCT06158399
Recruiting
AZA Combined With RCHOP in P53-mutated DLBCL.
Phase 2 · China · 1 site
Registry update: 19 Feb 2025
NCT06151080
Recruiting
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
Phase 2 · China · 1 site
Registry update: 19 Feb 2025
NCT06120166
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
Early phase 1 · China · 1 site
Registry update: 19 Sept 2025
NCT05934448
Recruiting
Pembro Plus CAR T-cell Therapy in R/R in PMBCL
Phase 2 · United States · 2 sites
Registry update: 5 Mar 2026
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Not applicable · United States · 6 sites
Registry update: 29 Oct 2026
NCT06026319
Recruiting
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Phase 1 · United States · 1 site
Registry update: 9 Oct 2026
NCT06176729
Recruiting
Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients
Phase 2 · China · 1 site
Registry update: 20 Dec 2023
NCT05984147
Recruiting
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Phase 1 · India · 27 sites
Registry update: 17 Apr 2026
NCT06022029
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Phase 1 · Australia, United States · 16 sites
Registry update: 24 Dec 2025
NCT06026488
Recruiting
Real-World Study of DLBCL With Different Genetic Subtypes
Not applicable · China · 1 site
Registry update: 19 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.